Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Ivabradine 7.5mg
You Searched
INAPURE 7.5 MG TABLET
₹155
Our Recommendation
Ivasmart 7.5mg Tablet 10s
1,126+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Angina (heart-related chest pain) INAPURE 7.5 MG TABLET is a heart rate lowering medication. It works by slowing down your heart rate. This lowers the heart?s need for oxygen, making it less likely that you will suffer chest pain. The medicine can reduce the frequency of angina attacks and help increase your ability to exercise and go about your daily life more efficiently. You should not stop taking it without your doctor?s advice, even if you feel well. In Treatment of Heart failure Heart failure is a condition where your heart cannot pump enough blood to the rest of your body. INAPURE 7.5 MG TABLET can be used in combination with other medicines to improve symptoms such as breathlessness, tiredness, and swelling and prevent heart failure from getting worse. This will improve your quality of life, allow you to go about your daily activities more easily, and decreases the risk of hospitalization in heart failure patients. This medicine needs to be taken regularly to be effective. Do not stop taking it until the doctor tells you so, even if you feel well.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. INAPURE 7.5 MG TABLET is to be taken with food.
INAPURE 7.5 MG TABLET is a heart rate lowering medication. It works by reducing the heart rate which lowers the oxygen requirement of the heart. As a result, the heart works more efficiently.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with INAPURE 7.5 MG TABLET . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: INAPURE 7.5 MG TABLET is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of INAPURE 7.5 MG TABLET during breastfeeding is not available. Doctor consultation is advised.
Not Safe: INAPURE 7.5 MG TABLET may cause side effects which could affect your ability to drive. INAPURE 7.5 MG TABLET may cause transient luminous phenomena consisting mainly of phosphenes. The possible occurrence of such luminous phenomena should be taken into account especially when driving at night.
Caution Advised: INAPURE 7.5 MG TABLET should be used with caution in patients with severe kidney disease. Dose adjustment of INAPURE 7.5 MG TABLET may be needed. Doctor consultation is advised. Limited information is available for use of INAPURE 7.5 MG TABLET in patients with severe kidney disease.
Caution Advised: INAPURE 7.5 MG TABLET should be used with caution in patients with liver disease. Dose adjustment of INAPURE 7.5 MG TABLET may be needed. Doctor consultation is advised. Use of INAPURE 7.5 MG TABLET is not recommended in patients with severe liver disease.
If you forget a dose of INAPURE 7.5 MG TABLET , simply continue with your regular schedule and do not take a double dose.
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Opie LH, Horowitz JD. Nitrates and Newer Antianginals ?-Blocking Agents. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 57
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 203-204
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Ivabradine (07 Jul. 2023)
Ivabradine (24 Mar. 2025)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.